Elsztain Fernando Adrian: insider trades.
Elsztain Fernando Adrian reported 11 non-derivative transactions on 7 SEC ownership filings in Q3 2026: 0 open-market purchases and 11 sales ($334K), across 2 companies.
- Transactions
- 11
- Purchases (P)
- 0
- Sales (S)
- 11
- Companies
- 2
- Name as filed
- Elsztain Fernando Adrian
Companies
| Company | Relationship | Transactions |
|---|---|---|
| Cresud Inc (CRESY) | Director | 10 |
| Irsa Investments & Representations Inc | Director | 1 |
Transactions
| Date | Company | Code | Shares | Price | Owned after | Filing |
|---|---|---|---|---|---|---|
| 2026-09-10 | Cresud Inc | S | 65,000 | $1.25 | 515,736 | Form 4 |
| 2026-09-09 | Cresud Inc | S | 35,000 | $1.19 | 580,736 | Form 4 |
| 2026-08-24 | Cresud Inc | S | 10,000 | $1.05 | 615,736 | Form 4 |
| 2026-08-20 | Cresud Inc | S | 10,000 | $1.1 | 625,736 | Form 4 |
| 2026-08-12 | Cresud Inc | S | 10,000 | $1.06 | 635,736 | Form 4 |
| 2026-07-22 | Cresud Inc | S | 20,000 | $1.17 | 645,736 | Form 4 |
| 2026-07-21 | Cresud Inc | S | 15,000 | $1.13 | 665,736 | Form 4 |
| 2026-07-06 | Cresud Inc | S | 4,385 | $1.11 | 680,736 | Form 4 |
| 2026-06-11 | Cresud Inc | S | 70,000 | $1.26 | 685,121 | Form 4 |
| 2026-04-21 | Cresud Inc | S | 31,000 | $1.16 | 755,121 | Form 4 |
| 2026-04-09 | Irsa Investments & Representations Inc | S | 5,524 | $1.69 | 0 | Form 4 |
Questions
What stock did Elsztain Fernando Adrian buy or sell?
Elsztain Fernando Adrian reported 11 non-derivative transactions on 7 SEC ownership filings in Q3 2026: 0 open-market purchases and 11 sales ($334K), across 2 companies.
Is Elsztain Fernando Adrian the same person as other filers with this name?
This page covers SEC CIK 2117577 only. The SEC assigns each reporting owner a CIK, and people with the same name have different CIKs.
Source: SEC Insider Transactions Data Sets, Q3 2026. Reported as filed; we do not assess intent, performance or compliance. All filings for this CIK on SEC.gov.
Plain-text version for agents and LLMs: /insiders/elsztain-fernando-adrian-2117577.md
Independent. Not affiliated with, endorsed by, or sponsored by the U.S. Securities and Exchange Commission. Data is reproduced from public SEC filings and datasets. Not investment advice.